Skip to main content
TipRanks
Go Ultimate75% OFF

Compare MapLight Therapeutics, Inc. (MPLT) vs. Competitors

38 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
MPLTMapLight Therapeutics, Inc.$6.65$369.58M-1.22-55.28%Moderate BuyUnlock the MPLT analyst price target with TipRanks PremiumMPLTUnlock the MPLT top-analyst price target with TipRanks Premium
SCNIScinai Immunotherapeutics$0.37$497.04K0.00-96.23%―Unlock the SCNI analyst price target with TipRanks PremiumMPLT vs SCNIUnlock the SCNI top-analyst price target with TipRanks Premium
GRIGRI Bio$1.27$2.95M-0.15-97.47%Moderate BuyUnlock the GRI analyst price target with TipRanks PremiumMPLT vs GRIUnlock the GRI top-analyst price target with TipRanks Premium
DRMADermata Therapeutics$0.54$2.81M-0.16-79.78%―Unlock the DRMA analyst price target with TipRanks PremiumMPLT vs DRMAUnlock the DRMA top-analyst price target with TipRanks Premium
AZTRAzitra Inc$0.57$3.68M-0.09-83.38%Moderate BuyUnlock the AZTR analyst price target with TipRanks PremiumMPLT vs AZTRUnlock the AZTR top-analyst price target with TipRanks Premium

Performance Comparison

-100%-50%0%50%100%150%200%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
MPLTMapLight Therapeutics, Inc.6.65-7.95-54.45%
SCNIScinai Immunotherapeutics0.37-9.53-96.29%
GRIGRI Bio1.27-46.05-97.32%
DRMADermata Therapeutics0.54-1.90-77.87%
AZTRAzitra Inc0.57-2.73-82.71%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts